We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FTC CLOSES ANTITRUST PROBE OF GENZYME-NOVAZYME COMBINATION
FTC CLOSES ANTITRUST PROBE OF GENZYME-NOVAZYME COMBINATION
January 14, 2004
In an action that suggests how the FTC might view other mergers of drug companies with competing preclinical research programs for rare diseases, the commission has closed its investigation into Genzyme’s 2001 acquisition of Novazyme Pharmaceuticals.